Verplaetse, Terril L.
Smith, Philip H.
Smith, Kathryn M. Z.
Oberleitner, Lindsay M.
McKee, Sherry A.
Funding for this research was provided by:
National Institutes of Health (UL1RR024139)
National Institute on Drug Abuse (T32DA007238)
Article History
Received: 16 August 2016
Accepted: 16 December 2016
First Online: 27 December 2016
Compliance with ethical standards
: This study was approved by the Yale Human Investigations Committee. Informed consent was obtained from all participants in accordance with the Declaration of Helsinki.
: SAM has consulting to Cerecor and Embera, has received research support for investigator-initiated studies from Pfizer, Inc., and has ownership in Lumme, Inc. All other authors declare that they have no conflict of interest.